|
|
Exchange: |
Nasdaq National Market |
Security
Type: |
Common |
Shares
Out: |
218,850,000 |
Market
Cap: |
39.94(B) |
Last
Volume: |
90,505,923 |
Avg
Vol: |
10,707,238 |
52
Week Range: |
$182.5 - $182.5 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Drug Manufacturers - Other |
|
Member Indexes:
|
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2024-01-28 |
2023-10-27 |
2023-04-28 |
2022-04-28 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Franchini Indrani Lall |
EVP, Chief Compliance Officer |
|
2021-06-08 |
4 |
D |
$177.00 |
$164,256 |
D/D |
(928) |
63,450 |
|
- |
|
Goff Brian |
EVP & Chief Commercial Officer |
|
2021-06-08 |
4 |
D |
$177.00 |
$192,222 |
D/D |
(1,086) |
90,688 |
|
- |
|
Mollen John T |
Director |
|
2021-05-20 |
4 |
A |
$0.00 |
$0 |
D/D |
2,635 |
15,336 |
|
- |
|
Brennan David R |
Director |
|
2021-05-20 |
4 |
A |
$0.00 |
$0 |
D/D |
3,336 |
20,873 |
|
- |
|
Friedman Paul A |
Director |
|
2021-05-20 |
4 |
A |
$0.00 |
$0 |
D/D |
2,495 |
12,840 |
|
- |
|
Dunsire Deborah |
Director |
|
2021-05-20 |
4 |
A |
$0.00 |
$0 |
D/D |
2,495 |
14,629 |
|
- |
|
Reinsdorf Judith A |
Director |
|
2021-05-20 |
4 |
A |
$0.00 |
$0 |
D/D |
2,635 |
14,150 |
|
- |
|
Nader Francois |
Director |
|
2021-05-20 |
4 |
A |
$0.00 |
$0 |
D/D |
2,635 |
13,921 |
|
- |
|
Rummelt Andreas |
Director |
|
2021-05-20 |
4 |
A |
$0.00 |
$0 |
D/D |
2,495 |
28,109 |
|
- |
|
Coughlin Christopher J |
Director |
|
2021-05-20 |
4 |
A |
$0.00 |
$0 |
D/D |
2,691 |
42,347 |
|
- |
|
Hantson Ludwig |
CEO |
|
2021-03-29 |
4 |
D |
$154.03 |
$359,198 |
D/D |
(2,332) |
349,166 |
|
- |
|
Carino Tanisha |
EVP & CCAO |
|
2021-03-01 |
4 |
D |
$151.75 |
$109,564 |
D/D |
(722) |
33,413 |
|
- |
|
Chiniara Ellen |
EVP & Chief Legal Officer |
|
2021-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
19,321 |
62,381 |
|
- |
|
Hantson Ludwig |
CEO |
|
2021-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
83,725 |
351,498 |
|
- |
|
Goff Brian |
EVP & Chief Commercial Officer |
|
2021-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
24,473 |
91,774 |
|
- |
|
Sarin Aradhana |
EVP, CFO |
|
2021-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
24,473 |
63,940 |
|
- |
|
Bazarko Daniel |
SVP, Controller, CAO |
|
2021-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
7,616 |
38,499 |
|
- |
|
Franchini Indrani Lall |
EVP, Chief Compliance Officer |
|
2021-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
18,033 |
64,378 |
|
- |
|
Orloff John J |
EVP, Research & Development |
|
2021-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
24,473 |
88,324 |
|
- |
|
Carino Tanisha |
EVP & CCAO |
|
2021-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
18,033 |
34,135 |
|
- |
|
Bazarko Daniel |
SVP, Controller, CAO |
|
2020-12-17 |
4 |
S |
$157.59 |
$3,795,233 |
D/D |
(24,066) |
30,883 |
|
-5% |
|
Bazarko Daniel |
SVP, Controller, CAO |
|
2020-12-17 |
4 |
OE |
$97.58 |
$2,816,740 |
D/D |
24,066 |
54,949 |
|
- |
|
Sarin Aradhana |
EVP, CFO |
|
2020-12-16 |
4 |
D |
$157.96 |
$1,478,979 |
D/D |
(9,363) |
39,467 |
|
- |
|
Sarin Aradhana |
EVP, CFO |
|
2020-12-16 |
4 |
A |
$0.00 |
$0 |
D/D |
15,371 |
48,830 |
|
- |
|
Orloff John J |
EVP, Research & Development |
|
2020-12-16 |
4 |
D |
$157.96 |
$3,379,554 |
D/D |
(21,395) |
63,811 |
|
- |
|
1501 Records found
|
|
Page 2 of 61 |
|
|